These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38412735)

  • 21. A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Cheng Y; Xu SM; Takenaka K; Lindner G; Curry-Hyde A; Janitz M
    Gene; 2023 Aug; 877():147568. PubMed ID: 37328077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2019 Dec; 17(1):401. PubMed ID: 31796045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sweetman E; Ryan M; Edgar C; MacKay A; Vallings R; Tate W
    Int J Immunopathol Pharmacol; 2019; 33():2058738418820402. PubMed ID: 30791746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Kerr J
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G; Maes M
    Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.
    Missailidis D; Annesley SJ; Allan CY; Sanislav O; Lidbury BA; Lewis DP; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Stanculescu D; Sepúlveda N; Lim CL; Bergquist J
    Front Neurol; 2021; 12():789784. PubMed ID: 34966354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study.
    Nakatomi Y; Mizuno K; Ishii A; Wada Y; Tanaka M; Tazawa S; Onoe K; Fukuda S; Kawabe J; Takahashi K; Kataoka Y; Shiomi S; Yamaguti K; Inaba M; Kuratsune H; Watanabe Y
    J Nucl Med; 2014 Jun; 55(6):945-50. PubMed ID: 24665088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.
    Mandarano AH; Maya J; Giloteaux L; Peterson DL; Maynard M; Gottschalk CG; Hanson MR
    J Clin Invest; 2020 Mar; 130(3):1491-1505. PubMed ID: 31830003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Induced by Repeated Forced Swimming in Mice.
    Ohba T; Domoto S; Tanaka M; Nakamura S; Shimazawa M; Hara H
    Biol Pharm Bull; 2019; 42(7):1140-1145. PubMed ID: 31257290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
    Holden S; Maksoud R; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 Jul; 18(1):290. PubMed ID: 32727475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS.
    Cheema AK; Sarria L; Bekheit M; Collado F; Almenar-Pérez E; Martín-Martínez E; Alegre J; Castro-Marrero J; Fletcher MA; Klimas NG; Oltra E; Nathanson L
    J Cell Mol Med; 2020 May; 24(10):5865-5877. PubMed ID: 32291908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
    Baos S; Brigden A; Anderson E; Hollingworth W; Price S; Mills N; Beasant L; Gaunt D; Garfield K; Metcalfe C; Parslow R; Downing H; Kessler D; Macleod J; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    Trials; 2018 Feb; 19(1):136. PubMed ID: 29471861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder.
    Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
    Neuro Endocrinol Lett; 2009; 30(4):470-6. PubMed ID: 20010505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.